Shape of Barrett's epithelium effects prevalence of erosive esophagitis

Feb 05, 2010

Barrett's epithelium is recognized as a complication of erosive esophagitis and is the pre-malignant condition for adenocarcinoma of the esophagus.

A research team from Yokohama City University School of Medicine hypothesized that some macroscopic features of Barrett's epithelium might be useful for identifying a subgroup with a high risk for the development of esophageal adenocarcinoma. Their study will be published on January 28, 2010 in the .

They enrolled 869 patients who underwent endoscopy during a health checkup at their hospital. Based on the Prague C & M Criteria, they originally classified cases of Barrett's epithelium into two types based on its shape, namely, flame-like and lotus-like Barrett's epithelium, and into two groups based on its length, its C extent < 2 cm, and ≥ 2 cm.

They found that Barrett's epithelium was diagnosed in 374 cases (43%). Most of these were diagnosed as short-segment Barrett's epithelium. The prevalence of erosive was significantly higher in subjects with flame-like than lotus-like Barrett's , and in those with a C extent of ≥ 2 cm than < 2 cm.

This study may represent a future strategy for intervention in the prevention of esophageal adenocarcinoma.

Explore further: Scientists to use tiny particles to fight big diseases

More information: Akiyama T, Inamori M, Iida H, Endo H, Hosono K, Sakamoto Y, Fujita K, Yoneda M, Takahashi H, Koide T, Tokoro C, Goto A, Abe Y, Shimamura T, Kobayashi N, Kubota K, Saito S, Nakajima A. Shape of Barrett's epithelium is associated with prevalence of erosive esophagitis. World J Gastroenterol 2010; 16(4): 484-489, www.wjgnet.com/1007-9327/16/484.asp

add to favorites email to friend print save as pdf

Related Stories

Researchers Shed Light on Esophageal Disease

Jun 08, 2009

(PhysOrg.com) -- Canadian Light Source (CLS) staff scientist Luca Quaroni and Dr. Alan Casson from the University of Saskatchewan used the synchrotron's infrared microscope to identify tissue afflicted with ...

Recommended for you

FOLFOXIRI plus bevacizumab ups outcome in metastatic CRC

12 hours ago

(HealthDay)—For patients with untreated metastatic colorectal cancer, chemotherapy with fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) plus bevacizumab improves outcome versus fluorouracil, ...

Cancer exosome 'micro factories' aid in cancer progression

16 hours ago

Exosomes, tiny, virus-sized particles released by cancer cells, can bioengineer micro-RNA (miRNA) molecules resulting in tumor growth. They do so with the help of proteins, such as one named Dicer. New research from The University ...

User comments : 0